Liver Diseases  >>  Zinbryta (daclizumab)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zinbryta (daclizumab) / Biogen, AbbVie
NCT00163657: Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection

Completed
4
312
US
Daclizumub, Zenapax, Tacrolimus, Prograf, Cyclosporine, Neoral, MMF, mycophenolate mofetil
Baylor Research Institute, Baylor Health Care System, Emory University, University of Southern California, Mayo Clinic - Scottsdale/Phoenix, Arizona, New York Presbyterian Hospital, Oregon Health and Science University, New York University, University of Cincinnati, University of Alabama at Birmingham, The University of Texas Health Science Center at San Antonio, University of Chicago, University of California, San Francisco, Mayo Clinic - Rochester, Minnesota, Medical University of South Carolina, University of Virginia, Lahey Clinic, University of Medicine and Dentistry of New Jersey, Northwestern Memorial Hospital
End Stage Liver Disease, Hepatitis C
04/06
01/07

Download Options